AVPT
AvePoint, Inc.
AVPT's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over AVPT overall, supported by stronger valuation and stronger modeled upside.
AVPT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Unavailable |
AVPT's revenue, profitability and cash flow are currently healthy. There isn't enough data to rate its balance sheet.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
AVPT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 34x | $16.38 | — |
| Cheap | 48x | $15.89 | -3% |
| Current | 50x | $16.38 | — |
| Fair | 66x | $21.92 | +34% |
| Expensive | 7,357x | $2,428 | +14722% |
Historical ranges are pointers, not guarantees.
AVPT's PE is in its cheap range at 50x. If earnings grow as analysts expect, today's price would be 34x next year's earnings.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over AVPT in the historical PE scenario, which offers more potential upside but is not a forecast.
AVPT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
AVPT has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
AVPT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.48 | +46% |
| Q3 2026 | $0.33 | +$0.33 |
| Q2 2026 | $0.31 | +$0.36 |
| Q1 2026 | $0.20 | +$0.33 |
| Q4 2025 | $0.15 | +$0.31 |
| Q3 2025 | $0.00 | +$0.05 |
| Q2 2025 | -$0.05 | +$0.03 |
| Q1 2025 | -$0.13 | -$0.05 |
| Q4 2024 | -$0.16 | -$0.04 |
AVPT has returned to profit: it earned $0.33 per share over the past year, after losing money the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over AVPT on earnings, with more consistent year-over-year improvement.
AVPT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $131.1M | +19% |
| Q2 2026 | $124.5M | +22% |
| Q1 2026 | $117.2M | +26% |
| Q4 2025 | $114.7M | +29% |
| Q3 2025 | $109.7M | +24% |
| Q2 2025 | $102M | +31% |
| Q1 2025 | $93.1M | +25% |
| Q4 2024 | $89.2M | +20% |
AVPT's revenue has grown year over year every quarter since mid-2022: $131M last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.7% | +1.3 points |
| Q2 2026 | 8.2% | +1.3 points |
| Q1 2026 | 11% | +7.3 points |
| Q4 2025 | 13% | +7.2 points |
| Q3 2025 | 7.4% | -1.2 points |
| Q2 2025 | 7% | +9.7 points |
| Q1 2025 | 3.5% | +7.8 points |
| Q4 2024 | 5.4% | +4.3 points |
AVPT's operating margin was 8.7% last quarter, up 1.3 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over AVPT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over AVPT on profitability, with a higher operating margin.
AVPT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $30M | -13% |
| Q2 2026 | $14.7M | -24% |
| Q1 2026 | $23M | +$24M |
| Q4 2025 | $29M | -9.5% |
| Q3 2025 | $34.3M | +11% |
| Q2 2025 | $19.3M | +22% |
| Q1 2025 | -$1M | -114% |
| Q4 2024 | $32M | +54% |
AVPT generated $97M in free cash flow over the past year, up 14% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over AVPT on cash flow, with more consistent year-over-year improvement.
AVPT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +1.1M shares |
| 1 year | -4.7% | -10.9M shares |
| 3 years | +22% | +40.2M shares |
| 5 years | +534% | +187M shares |
AVPT has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $30.9M |
| Q2 2026 | $50.5M |
| Q1 2026 | $59.8M |
| Q4 2025 | $22.4M |
| Q3 2025 | $8.4M |
| Q2 2025 | $7M |
| Q1 2025 | $11.9M |
| Q4 2024 | $11.3M |
AVPT spent $164M buying back its own shares over the past year, about four times what it spent the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
AVPT Net Leverage
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
AVPT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 66.0 | Neutral |
| Stochastic | 83.1 | Overbought |
AVPT's weekly RSI is 66 (neutral) and its Stochastic is 83 (overbought).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
AVPT PE vs Technology Sector
| Metric | AVPT | Sector median | Relative |
|---|---|---|---|
| PE | 50x | 28x | 78% above |
| PE % | 18 | 35 | 17 pts below |
AVPT is trading at 50x earnings, a 78% premium to the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over AVPT on valuation relative to its sector.
AVPT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.3 | 6.9% above |
| 20 week MA | $13.9 | 18% above |
| 50 week MA | $12.3 | 33% above |
| 100 week MA | $14.3 | 14% above |
| 200 week MA | $11.3 | 45% above |
AVPT has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
AVPT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.90 | $16.3 | +65% |
| 2021 | $16.3 | $6.50 | -60% |
| 2022 | $6.50 | $4.27 | -34% |
| 2023 | $4.27 | $8.21 | +92% |
| 2024 | $8.21 | $17.0 | +106% |
| 2025 | $17.0 | $13.8 | -19% |
| 2026 YTD | $13.8 | $16.4 | +19% |
AVPT has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.